Negative Impact of the COVID-19 Pandemic on Kidney Disease Management—A Single-Center Experience in Romania

Abstract

Background: The evolution of the COVID-19 pandemic affected healthcare systems worldwide. The patients with chronic kidney disease (CKD), diabetes, and cardiovascular disease were most affected and had an unfavorable outcome. Methods: We examined the activity of the Nephrology Department from Târgu-Mureș County Emergency Hospital retrospectively, comparing two periods: June 2020–November 2021 (COVID-19 period) and June 2018–November 2019 (non-COVID-19 period). Results: In the COVID-19 period, there were fewer one-day hospitalizations registered, 77.27% more dialysis catheters were installed, and 43.75% more arteriovenous fistulas were performed. An overall increase in the number of patients requiring dialysis during the pandemic was recorded, as of the number of dialysis sessions performed. Moreover, we observed a statistically significant increase in the number of dialysis sessions per patient and a statistically significant increase in the number of hospitalization days in the pandemic interval. Acute kidney injury (AKI) and urosepsis were the diagnoses that increased the most among in-patients during the pandemic, while all other nephrology diagnoses decreased. Conclusions: The COVID-19 pandemic accelerated kidney pathology and worsened the outcomes of nephrology patients in our center. The number of chronic and patient’s access to one-day hospitalization decreased in order to minimalize the exposure and the risk of infection. In contrast, the need for emergency dialysis increased significantly.

Chest CT Severity Score and Systemic Inflammatory Biomarkers as Predictors of the Need for Invasive Mechanical Ventilation and of COVID-19 Patients’ Mortality

“…Due to the rapid spread of the SARS-Cov-2 (severe respiratory syndrome coronavirus 2) infection, the World Health Organization (WHO) declared the outbreak of the COVID-19 pandemic on 11 March 2020, which has become a global phenomenon and public health problem, which in the last two years had a negative impact on current medical practice [ 1 , 2 , 3 ]. Despite the development of antiviral therapies, severe forms of the disease require intensive therapy and have a high mortality rate [ 4 , 5 ].…”

Prognostic Nutritional Index, Controlling Nutritional Status (CONUT) Score, and Inflammatory Biomarkers as Predictors of Deep Vein Thrombosis, Acute Pulmonary Embolism, and Mortality in COVID-19 Patients

“…From December 2019 until now (16 October 2022), the Coronavirus disease (COVID-19) has affected over 629 million people and caused 6,571,064 deaths worldwide, having a negative impact on the medical practice [ 1 , 2 , 3 ].…”

Systemic Inflammatory Biomarkers and Chest CT Findings as Predictors of Acute Limb Ischemia Risk, Intensive Care Unit Admission, and Mortality in COVID-19 Patients

“…The pandemic caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) has affected, until the present day (26 August 2022), a total of 604,392,189 cases and caused 6,483,256 deaths [ 1 ], having a negative impact on medical activities [ 2 , 3 ]. Patients’ symptoms range from minor (headache, loss of taste and smell) to severe (major lung damage, admission to critical care units, the necessity of invasive mechanical ventilation, sepsis, and, more recently, thromboembolic events) [ 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 ].…”